Lovastatin may prevent development of cardiovascular disease (CVD) in CKD patients, according to study findings published in the American Journal of Kidney Diseases (2009; published online ahead of print).

The study included 5,608 men and 997 women without CVD randomized to receive either lovastatin or placebo.

After an average follow-up of 5.3 years, lovastatin recipients had a 69% decreased risk of a CVD event compared with the placebo arm, after adjusting for potential confounders.

Continue Reading